GlassScriptFilmarray Bcid2 Control Panel M416
Payments companies reported to CMS as associated with Filmarray Bcid2 Control Panel M416. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Filmarray Bcid2 Control Panel M416, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Filmarray Bcid2 Control Panel M416
These are the largest totals companies reported as associated with Filmarray Bcid2 Control Panel M416. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Daniel Feinstein | Pinehurst, NC | Critical Care Medicine (Internal Medicine) | $2,222.50 |
| Joan Guevarra | Nesconset, NY | General Practice | $187.47 |
| Jeby Abraham | Watertown, NY | Internal Medicine | $135.58 |
| Vijesh Patel | Watertown, NY | Internal Medicine | $135.58 |
| Javeed Siddiqui | Roseville, CA | Infectious Disease | $124.67 |
| Suhail Abbasi | Batavia, NY | Internal Medicine | $51.89 |
| Aruna Ray | Watertown, NY | Nephrology (Internal Medicine) | $51.89 |
| Abdur Jamil | Saginaw, MI | Internal Medicine | $51.89 |
| Shehroz Aslam | Watertown, NY | Internal Medicine | $51.89 |
| Marylene Duah | Watertown, NY | Infectious Disease | $50.15 |
Prescribed Filmarray Bcid2 Control Panel M416?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.